Both groups had normal HbA1c glycosylation levels, and overweight was lower in patients taking insulin Detemir than in NPH patients, while hypoglycemia has been lower in patients treated by insulin Detemir; and the weight loss of the patients was attributed to insulin Detemir (16). The gene discussed is INS; the disease is Hypoglycemia.